Fresenius Kabi Oncology Limited Etoposide Export Data — India (DGFT 2022–2026)

Name: Fresenius Kabi Oncology Limited Etoposide Export Records India — #2 Exporter, 126 Shipments, $1.9M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Etoposide

India Pharmaceutical Trade Intelligence

$10.8M237 Suppliers122 CountriesHS 30049045

ExportsIndia → UNITED STATES23.1%India → NETHERLANDS9.2%

ImportsGERMANY → India$492 UNITED STATES → India$402

#1 Supplier: INTAS PHARMACEUTICALS #1 Buyer: EVERSANA LIFE

Fresenius Kabi Oncology Limited — Etoposide Exporter #2 | $1.9M Trade Value | TransData Nexus | TransData Nexus

Fresenius Kabi Oncology Limited — Etoposide Exporter Profile

Indian Pharmaceutical Exporter · #2 for Etoposide · $1.9M export value · DGFT Verified

Fresenius Kabi Oncology Limited is the #2 Indian exporter of Etoposide with $1.9M in export value and 126 verified shipments. Fresenius Kabi Oncology Limited holds a 17.3% market share in Etoposide exports across 20 countries. The company exports 16 pharmaceutical products worth $117.2M across 3 therapeutic categories.

Fresenius Kabi Oncology Limited — Etoposide Export Profile: Buyers & Destinations

Fresenius Kabi Oncology Limited Etoposide export treemap — buyers and destination countries | TransData Nexus

Where Does Fresenius Kabi Oncology Limited Export Etoposide?

Country	Value	Shipments	Share
GERMANY	$471.8K	22	25.4%
TAIWAN	$332.8K	14	17.9%
THAILAND	$251.8K	12	13.6%
MALAYSIA	$234.3K	12	12.6%
PAKISTAN

Who Are the Top Buyers of Etoposide from Fresenius Kabi Oncology Limited?

Buyer	Country	Value	Orders
FRESENIUS KABI DEUTSCHLAND GMBH	GERMANY	$471.8K	22
FRESENIUS KABI MALAYSIA SDN BHD	MALAYSIA	$180.4K	9
FRESENIUS KABI TAIWAN LTD	TAIWAN	$135.5K	4
FRESENIUS KABI (THAILAND) LTD	THAILAND	$103.4K	5
FRESENIUS KABI TAIWAN LTD.	TAIWAN	$78.3K	3
ATCO PHARMA INTERNATIONAL (PVT) LTD	PAKISTAN	$70.1K	3
FRESENIUS KABI TAIWAN LIMITED	TAIWAN	$65.9K	3
FRESENIUS KABI SOUTH AFRICA PTY	SOUTH AFRICA	$50.0K	1
ATCO PHARMA INTERNATIONAL PVT LTD	PAKISTAN	$48.9K	5
PT. FRESENIUS KABI INDONESIA	INDONESIA	$48.0K	6

Fresenius Kabi Oncology Limited supplies Etoposide to 51 buyers globally. The largest buyer is FRESENIUS KABI DEUTSCHLAND GMBH (GERMANY), followed by FRESENIUS KABI MALAYSIA SDN BHD (MALAYSIA) and FRESENIUS KABI TAIWAN LTD (TAIWAN). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Etoposide Formulations Does Fresenius Kabi Oncology Limited Export?

Product Description / Formulation	Value	Shipments
FYTOSID (ETOPOSIDE) INJ. 100MG/5ML VIAL	$129.3K	6
FYTOSID (ETOPOSIDE) INJ. USP 100MG/5ML V	$107.8K	6
ETOPOSIDE INJ. 100MG/5ML VIAL BATCH NO.87250041AC, MFG. DT. 02/2025, EXP. DT.01/2027	$63.2K	2
FYTOSID ETOPOSIDE USP INJ 100MG 5ML VIAL BATCH NO 87250163AB MFG DT 05 2025 EXP DT 04 2027	$59.6K	2
ETOPOSIDE-KABI (ETOPOSIDE) INJ. 100MG/5ML VIAL BATCH NO.87230346AA, MFG. DT. 07/2023, EXP. DT. 06/2025NOS	$55.1K	3
FYTOSID (ETOPOSIDE) USP INJ. 100MG/5ML V	$50.2K	6
Etoposide Etoposide Fresenius Inj. 100	$50.0K	1
ETOPOSIDE INJ. 100MG/5ML VIAL BATCH NO.87230537AA MFG. DT. 12/2023 EXP. DT.11/2025NOS	$50.0K	1
ETOPOSIDE INJ. 100MG/5ML VIAL, BATCH NO.87240153AA, MFG. DT. 04/2024, EXP. DT.03/2026	$50.0K	1
ETOPOSIDE INJ. 100MG/5ML VIAL BATCH NO.87230429AA MANUFACTURING . DT. 09/2023 EXP. DT.08/2025	$44.9K	1

Fresenius Kabi Oncology Limited exports 98 distinct Etoposide formulations including tablets, capsules, syrups, and combination drugs. The top formulation is FYTOSID (ETOPOSIDE) INJ. 100MG/5ML VIAL with 6 shipments worth $129.3K.

How Does Fresenius Kabi Oncology Limited Compare to Nearest Etoposide Exporters?

Exporters ranked immediately above and below #2 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	INTAS PHARMACEUTICALS LIMITED	$4.8M	580	11	$8.3K
2	FRESENIUS KABI ONCOLOGY LIMITED ★	$1.9M	126	20	$14.9K
3	VENUS REMEDIES LIMITED	$988.8K	139	20	$7.1K
4	MYLAN LABORATORIES LIMITED	$350.0K	7	2	$50.0K

Fresenius Kabi Oncology Limited ranks #2 among 237 Indian Etoposide exporters. Average shipment value of $14.9K compared to the market average of $40.3K. The closest competitors by value are INTAS PHARMACEUTICALS LIMITED and VENUS REMEDIES LIMITED.

Which Indian Ports Ship Etoposide Exports?

Port	Shipments	% Share
SAHAR AIR	357	16.8%
SAHAR AIR CARGO ACC (INBOM4)	333	15.6%
DELHI AIR	258	12.1%
DELHI AIR CARGO ACC (INDEL4)	244	11.5%
AHEMDABAD AIR ACC (INAMD4)	141	6.6%
AHEMDABAD AIR	135	6.3%
MUNDRA SEA (INMUN1)	129	6.1%
Bombay Air	96	4.5%

Geopolitical & Trade Policy Impact on Fresenius Kabi Oncology Limited's Etoposide Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like FKOL. The Israel-Iran conflict has led to disruptions in Red Sea shipping routes, causing maritime carriers to suspend bookings and reroute vessels around the Cape of Good Hope. These changes have resulted in increased freight charges and extended transit times, posing significant risks to time-sensitive pharmaceutical shipments. The Pharmaceutical Export Promotion Council of India (Pharmexcil) estimates potential losses ranging from ₹2,500 crore to ₹5,000 crore due to these disruptions. (fortuneindia.com)

Conversely, U.S.-China trade tensions have created openings for Indian pharmaceutical companies. The U.S. has imposed tariffs on Chinese goods, including pharmaceuticals, prompting American importers to seek alternative suppliers. This shift has benefited Indian exporters, as evidenced by the U.S. accounting for approximately 34.5% of India's pharma exports, valued at around $10.5 billion. (actizaindustry.com) However, the U.S. administration's fluctuating tariff policies, including threats of increased tariffs on pharmaceutical imports, necessitate vigilance and adaptability from exporters like FKOL. (lemonde.fr)

In the European Union, regulatory changes such as the Falsified Medicines Directive (FMD) impose stringent requirements on pharmaceutical imports. Compliance with these regulations demands significant investment in serialization and traceability systems. For FKOL, ensuring adherence to such standards is crucial to maintaining access to the lucrative EU market and upholding its reputation for quality and reliability.

Fresenius Kabi Oncology Limited — Regulatory Compliance & Quality Standards

The global pharmaceutical industry is witnessing heightened regulatory scrutiny, with agencies like the FDA and WHO emphasizing Good Manufacturing Practices (GMP) compliance. Indian exporters, including FKOL, must navigate this evolving landscape to sustain their market positions. Notably, the FDA has increased inspections of Indian manufacturing facilities, with over 200 inspections conducted in 2023 and plans to escalate this number in 2024. (fact.net.in)

FKOL's commitment to quality is evident in its state-of-the-art Research & Development center in Gurgaon, India. The facility focuses on developing next-generation cytotoxic and cytostatic therapies, ensuring that products meet the highest quality standards irrespective of the target market. (fresenius-kabi-oncology.com) This proactive approach to quality assurance positions FKOL favorably in a competitive and regulated global market.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Etoposide shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Fresenius Kabi Oncology Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 126 individual customs records matching Fresenius Kabi Oncology Limited exporting Etoposide, covering 98 formulations to 20 countries via 51 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 122+ countries, 598+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Etoposide

Etoposide

Fresenius Kabi Oncology Limited — Etoposide Exporter Profile

Fresenius Kabi Oncology Limited — Etoposide Export Profile: Buyers & Destinations

Where Does Fresenius Kabi Oncology Limited Export Etoposide?

Who Are the Top Buyers of Etoposide from Fresenius Kabi Oncology Limited?

What Is India's Total Etoposide Export Value and How Much Does Fresenius Kabi Oncology Limited Contribute?

What Is the Average Shipment Value for Fresenius Kabi Oncology Limited's Etoposide Exports?

How Does Fresenius Kabi Oncology Limited Compare to Other Indian Etoposide Exporters?

What Etoposide Formulations Does Fresenius Kabi Oncology Limited Export?

Regulatory Requirements: Exporting Etoposide to Key Markets

Germany — BfArM/EMA

How Does Fresenius Kabi Oncology Limited Compare to Nearest Etoposide Exporters?

Which Indian Ports Ship Etoposide Exports?

What Other Oncology Products Does Fresenius Kabi Oncology Limited Export?

Geopolitical & Trade Policy Impact on Fresenius Kabi Oncology Limited's Etoposide Exports

Fresenius Kabi Oncology Limited — Regulatory Compliance & Quality Standards

About Fresenius Kabi Oncology Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Etoposide Export Data from Fresenius Kabi Oncology Limited

Etoposide Stats

Company Overview

Top Products by Fresenius Kabi Oncology Limited

Related Analysis

Need Detailed Export Data?

Data Source